When treating patients with moderate to severe psoriasis, physician-patient interaction, patient education, and information delivery are important factors in optimizing adherence and treatment outcomes, according to a recent study by Zschocke and colleagues.1 Researchers found that physician-patient communication also improved positive personal interrelations between dermatologists and their patients.
Historically, treatment efficacy of biologic agents in patients with psoriasis has reported higher patient adherence compared to traditional therapies.
The non-interventional retrospective multicenter trial study was conducted to provide information on adherence in patients with psoriasis. Researchers developed questionnaires, which were based on the adherence dimensions identified by the World Health Organization, and they were sent to and completed by 13 dermatologists and 246 patients. Study data was analyzed for potential predictors of adherence in an explorative manner.
Based on the physician’s assessment of the patients’ individual adherence, subsets of adherent and non-adherent patients were discriminated. Researchers identified 2 main drivers that were positively connected to patient adherence—a lack of efficacy of the previous treatment, and the knowledge of comorbidities associated with severe psoriasis.
“Furthermore, physician-patient communication seems to play a central role, as on the dermatologists' side, there was a strong association of adherence and positive personal interrelation between dermatologist and patient,” they reported.
—Julie Gould
Reference:
- Zschocke I, Ortland C, Reich K. Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: The importance of physician-patient interaction and communication. Published online Febraury 21, 2017. J Eur Acad Dermatol Venereol.
When treating patients with moderate to severe psoriasis, physician-patient interaction, patient education, and information delivery are important factors in optimizing adherence and treatment outcomes, according to a recent study by Zschocke and colleagues.1 Researchers found that physician-patient communication also improved positive personal interrelations between dermatologists and their patients.
Historically, treatment efficacy of biologic agents in patients with psoriasis has reported higher patient adherence compared to traditional therapies.
The non-interventional retrospective multicenter trial study was conducted to provide information on adherence in patients with psoriasis. Researchers developed questionnaires, which were based on the adherence dimensions identified by the World Health Organization, and they were sent to and completed by 13 dermatologists and 246 patients. Study data was analyzed for potential predictors of adherence in an explorative manner.
Based on the physician’s assessment of the patients’ individual adherence, subsets of adherent and non-adherent patients were discriminated. Researchers identified 2 main drivers that were positively connected to patient adherence—a lack of efficacy of the previous treatment, and the knowledge of comorbidities associated with severe psoriasis.
“Furthermore, physician-patient communication seems to play a central role, as on the dermatologists' side, there was a strong association of adherence and positive personal interrelation between dermatologist and patient,” they reported.
—Julie Gould
Reference:
- Zschocke I, Ortland C, Reich K. Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: The importance of physician-patient interaction and communication. Published online Febraury 21, 2017. J Eur Acad Dermatol Venereol.
When treating patients with moderate to severe psoriasis, physician-patient interaction, patient education, and information delivery are important factors in optimizing adherence and treatment outcomes, according to a recent study by Zschocke and colleagues.1 Researchers found that physician-patient communication also improved positive personal interrelations between dermatologists and their patients.
Historically, treatment efficacy of biologic agents in patients with psoriasis has reported higher patient adherence compared to traditional therapies.
The non-interventional retrospective multicenter trial study was conducted to provide information on adherence in patients with psoriasis. Researchers developed questionnaires, which were based on the adherence dimensions identified by the World Health Organization, and they were sent to and completed by 13 dermatologists and 246 patients. Study data was analyzed for potential predictors of adherence in an explorative manner.
Based on the physician’s assessment of the patients’ individual adherence, subsets of adherent and non-adherent patients were discriminated. Researchers identified 2 main drivers that were positively connected to patient adherence—a lack of efficacy of the previous treatment, and the knowledge of comorbidities associated with severe psoriasis.
“Furthermore, physician-patient communication seems to play a central role, as on the dermatologists' side, there was a strong association of adherence and positive personal interrelation between dermatologist and patient,” they reported.
—Julie Gould
Reference:
- Zschocke I, Ortland C, Reich K. Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: The importance of physician-patient interaction and communication. Published online Febraury 21, 2017. J Eur Acad Dermatol Venereol.
